Dr Elizabeth M Haddad, MD | |
1701 N George Mason Dr, Arlington, VA 22205-3610 | |
(703) 558-5000 | |
Not Available |
Full Name | Dr Elizabeth M Haddad |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 27 Years |
Location | 1701 N George Mason Dr, Arlington, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699716514 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 0101232799 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virginia Hospital Center | Arlington, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dominion Anesthesia Pllc | 7618863713 | 64 |
News Archive
Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the September 12 issue of JAMA.
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
A startling paper by a team of French scientists published in the preprint journal bioRxiv in April 2020 suggests that the novel coronavirus is capable of surviving at high temperatures. This could mean that laboratory technicians handling the virus are at danger of infection.
› Verified 8 days ago
Entity Name | Dominion Anesthesia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073554952 PECOS PAC ID: 7618863713 Enrollment ID: O20040305000503 |
News Archive
Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the September 12 issue of JAMA.
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
A startling paper by a team of French scientists published in the preprint journal bioRxiv in April 2020 suggests that the novel coronavirus is capable of surviving at high temperatures. This could mean that laboratory technicians handling the virus are at danger of infection.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Elizabeth M Haddad, MD 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Dr Elizabeth M Haddad, MD 1701 N George Mason Dr, Arlington, VA 22205-3610 Ph: (703) 558-5000 |
News Archive
Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the September 12 issue of JAMA.
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.
A startling paper by a team of French scientists published in the preprint journal bioRxiv in April 2020 suggests that the novel coronavirus is capable of surviving at high temperatures. This could mean that laboratory technicians handling the virus are at danger of infection.
› Verified 8 days ago
Robert Minh Cao Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1860 N Scott St Apt 639, Arlington, VA 22209 Phone: 337-534-9256 | |
Dr. Mushfique Ahmed, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Krupa Bipin Patel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Marina Pavlova, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-5000 | |
John M Huffman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr Ste 150, Arlington, VA 22205 Phone: 571-732-0044 Fax: 866-850-1049 | |
Ashley Tran, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Peter Glass, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1525 Wilson Blvd Ste 540, Arlington, VA 22209 Phone: 202-315-5223 |